[Funding alert] MA-based MitoSense Secures $3.5Million in Seed Funding
Jan 22, 2024 | By Devin Jacobs
MA-based MitoSense secures $3.5million in seed funding. Lead the funding round was Caydan Capital Partners. The funding will be used by the company to further its cutting-edge research in the field of mitochondrial organelle transplantation (MOTTM).
Follow us
Follow usMitoSense is a biotechnology business that focuses on developing treatments for neurodegenerative illnesses and is committed to improving mitochondrial health through novel therapeutics and research.
Read also - WA-based Oleria Secures $33.1M in Series A Round Funding
Numerous neurodegenerative illnesses, including Huntington's, Parkinson's, multiple sclerosis, and others, may be treated with this technology.
RECOMMENDED FOR YOU
GA-based Apptega Secures $15Million in Growth Funding – FUNDING NEWS
Devin Jacobs
May 1, 2024
[Funding alert] CA-based Avenzo Therapeutics, Inc Secures $150Million in Series A-1 Round Funding
Devin Jacobs
Mar 27, 2024
About MitoSense
MitoSense are a research and development firm that possesses patent-pending technology that is uniquely licenced. Their technique replenishes mitochondria to combat disease, especially neurological illnesses like Parkinson's, Alzheimer's, and ALS.
Read also - Conn.-based Kusari Secures $8m in Pre-Seed & Seed Funding
Recommended Stories for You
Team SR Aug 9, 2024
Startuprise Sep 18, 2025
Devin Jacobs Sep 14, 2024
Devin Jacobs Apr 23, 2024
Startuprise Feb 24, 2026
Devin Jacobs Apr 22, 2026
Trending Stories
[Funding alert] CA-based Proto Hologram Secures an Investment from Cartan Capital
[Funding News] Decagon Secures $100 Mn Series B Funding
Worldscape Raises $10M Seed Extension Led by Scout Ventures
Washington-Based Buywander Raises $21M in Series A Funding
Skims Appoints Erin Magee as Chief Design Officer
Karoo Health Bags $16.2M in Series A Funding Round
Baselayer Raises $35M in Series A Funding Led by M13
Chris Moxham Co-founded Transcripta Bio Scores $24M in Funding
